Litcius/Paper detail

Development and validation of an UPLC-ESI-MS/MS method for quantification of duvelisib in plasma: application to pharmacokinetic study in rats

Ibrahim A. Darwısh, Nourah Z. Alzoman, Aliyah Almomen, Abdulrahman A. Almehizia, Mohamed W. Attwa, Hany W. Darwish, Ahmed Y. A. Sayed

2023RSC Advances13 citationsDOIOpen Access PDF

Abstract

of the drug. The methodology is distinguished by excellent sensitivity, accuracy, and ease of sample pretreatment. Furthermore, it is efficient and has a short run time, which makes it high throughput and accordingly enables faster processing of many samples in clinical laboratories.

Topics & Concepts

ChromatographyDetection limitChemistryProtein precipitationAmmonium formatePharmacokineticsReproducibilityBioanalysisReagentAnalyteAnalytical Chemistry (journal)AcetonitrilePharmacologyMedicinePhysical chemistryChronic Lymphocytic Leukemia ResearchImmunodeficiency and Autoimmune DisordersPI3K/AKT/mTOR signaling in cancer
Development and validation of an UPLC-ESI-MS/MS method for quantification of duvelisib in plasma: application to pharmacokinetic study in rats | Litcius